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From the 
President 
On June 3 & 4, 
the Board held 
its first retreat since September 1992. 
The participants were expanded to 
include Senior Administration, all 
Clinical Chairs, and TROIKA 
(collectively, the Senior Management 
Council). The purpose of this retreat 
centered on three concepts: (1) 
Functional Plan, (2) Governance, and 
(3) Physician Practice Organizations. 
The Functional Plan addressed short 
term and long-range plans for Lehigh 
Valley Health Network. Immediate 
projects include the acute inpatient 
consolidation at Cedar Crest, outpatient 
surgery, Fast Track E.R., OB services, 
etc. Concurrently planning on future 
programs and operational requirements 
involving the downsizing of the 
inpatient hospital and developing 
ambulatory requirements; ultimately, a 
complete master facility plan to address 
our long-term needs are included in the 
functional planning process. The 
Board will further address the 
functional plan at its July meeting. 
The second topic of Governance 
addressed the clarification of Board: 
Senior Management Council roles. 
Established was the authority and 
responsibility of the CEO and Senior 
Management Council for management 
decisions. The Board of Trustees have 
the ultimate authority for the 
governance of the network and its 
divisions. Medical Executive 
Committee will continue its 
authority/responsibility for quality 
assurance and credentials, answering to 
the Q.A./Staff Development Committee 
9f the Board of Trustees and to the 
Board of Trustees. 
Joe Lyons, Executive Director of 
Lehigh Valley Physician Group, 
presented details of the physician group 
followed by John VanBrakle's eloquent 
review of the pediatric physicians 
group, detailing that department's 
organization and plans. Finally, I 
presented the practice model 
represented by the majority of the 
medical staff. Healthy discussion 
ensued with the realization that 
different physician organizations will 
be part of the Lehigh Valley Health 
Network. 
I would encourage all members of our 
medical staff to further review these 
topics with their department chairs and 
TROIKA. For more details about the 
retreat, refer to pages 4 and 5 of the 
newsletter. 
Continued on Page 2 
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We welcome Richard Boorse, Paul 
Guillard, James Jaffe, and Jay 
Kaufman to the Medical Executive 
Committee and anticipate their 
contributions. A special Thank You to 
Carl D'Angelo, Mark Gittleman, Glenn 
Kratzer, Joe Gastinger, and Jim 
Goodreau for their dedication and 
service to the medical staff as members 
of Medical Executive Committee. 
I will update the search committees in 
the next newsletter, but one search has 
been completed. The COO search 
committee has completed its work and 
Elliot has hired Lou Liebhaber as 'our 
new COO. Lou comes from Mt. Sinai 
in New York where he has enjoyed 
success in hospital administration in 
working with a very large medical staff 
of multiple practice organizations. 
Site· and Facilities Update 
17th & Chew 
Renovations to Begin for Ambulatory 
Surgery 
Renovations to the second floor tower 
will begin in late June for an 
ambulatory surgery suite that will 
adjoin the Operating Room suites. 
Open House Planned for 
Mother/Baby Unit 
The Mother/Baby Unit will relocate to 
newly-renovated quarters on 4T in mid 
June. The new unit will accommodate 
postpartum mothers and their babies in 
predominantly single rooms with 
private bath facilities. 
Also, Jim Burke has been hired as the 
Vice President for Site Operations at 
17th &. Chew. Jim is from the 
Hospital of the University of 
Pennsylvania and also should represent 
a wonderful addition. Jim of course ' ' 
will be involved in the development of 
the ambulatory/surgical services and 
will be seeking our input. Please make 
him and Lou (due to start in July) 
welcome. 
A final note, please return the PHO 
survey information and be a candidate 
to spend a weekend in Bermuda. 
Wishing all a great summer. 
11-Candio, M.D. 
President, Medical Staff 
Later this month, renovations will 
begin on 3T, the area now occupied by 
the Mother/Baby Unit, for 10 new 
labor/Delivery/Recovery (LDR) 
rooms. Subsequently, the existing 
labor and Delivery Unit will be 
~sformed into a high-risk antepartum 
umt for mothers who require 
hospitalization during pregnancy. 
General Upgrades 
Electrical, plumbing and other 
upgrades to the hospital infrastructure 
on the second to sixth floor, T wing 
are scheduled to be completed this 
month. 
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Rehabilitative Services to Relocate 
Physical and occupational therapy will 
relocate to the fifth floor tower in late 
June, following inspection by the 
Division of Hospitals and the Life 
Safety Division of the State 
Department of Health. These 
rehabilitative services will adjoin the 
transitional, or sub-acute care unit now 
under review by the Pennsylvania 
Department of Health. 
Outpatient Treatment Unit Relocates 
The Outpatient Treatment Unit has 
expanded from eight to twelve bays at 
its new location on 4N. 
Cedar Crest & 1-78 
Renovations Proceedin& for 
ExpressCare 
Renovations are proceeding on 
schedule in the former offices of 
Medical Staff Services which will be 
converted into a four-bay treatment 
area for ExpressCare, emergency 
treatment for minor illness or injury. 
The new treatment setting will adjoin 
the patient registration area in the 
Emergency Department. Expresscare 
is scheduled to be available on July 1. 
Fourth Floor of Cancer Center to 
House Offices 
Human Resources, Legal Services/Risk 
Management, IntegrcLted Quality 
Assessment/Resource Utilization 
Management (IQA/RUM), the 
Information Services Training Room, 
and the Credit Union will occupy new 
offices on the fourth floor of the John 
and Dorothy Morgan Cancer Center, in 
accordance with the hospital's original 
plans for the facility. In addition, ~ew 
physician offices will occupy the third 
floor of the Cancer Center. The 
offices will be ready for occupancy in 
early August. Eventually, the Cancer 
Center will house many of the 
departments which now occupy the 
trailers as well as other consolidated 
departments. 
Administrative Services Relocation 
Administrative offices adjacent to the 
lobby will be relocated to an 
administrative suite for senior 
management on the third floor of the 
Anderson Wing. The administrative 
suite is now under construction and 
scheduled for completion in mid-July. 
The Board of Trustees conference 
room will be relocated to this area as 
well. 
Physical Therapy/Occupational 
Therapy and Cardiac Cath Lab 
Renovations to the physical and 
occupational therapy departments and 
cardiac cath lab No. 3 have been 
completed. 
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Trustees, Leadership Retreat Held· 
Lehigh Valley Hospital Trustees, the 
Pool Health Care Trustees and the 
Senior Management Council, which 
includes members of TROIKA, 12 
Department Chairs, and Senior 
Administration, participated in a retreat 
held on Friday, June 3 and Saturday, 
June 4 at the Holiday Inn in 
Fogelsville. 
The meeting focused on the review of 
three major initiatives, a decision 
making matrix which defined the role 
and responsibilities of the Board of 
Trustees and Senior Management, 
recommendations from the functional 
planning process, and the status of the 
Physician Hospital Organization and its 
related entities. 
A decision making matrix, which will 
be distributed to all physicians and 
staff, defined the decision making 
relationship and responsibilities 
between the Board of Trustees, the 
Chief Executive Officer and Senior 
Management Council. 
It was unanimously agreed that while 
the Board would continue its role in 
governance, i.e., setting the broad 
direction for the organization and 
setting policy, the responsibility for 
recommending and managing policy 
development, strategy and tactics to 
achieve specific goals and operations 
would be the responsibility of the Chief 
Executive Officer and the members of 
the Senior Management Council. 
The matrix will clarify for the medical 
staff and management at Lehigh Valley 
Hospital and its operating divisions the 
process by which decisions are 
reviewed and acted upon. Members o .. 
the medical staff will receive this 
material as soon as it receives final 
review at Senior Management Council. 
The second major topic reviewed the 
preliminary recommendations of the 
10-month functional planning process 
which began last August when the firm 
of Hamilton/KSA of Virginia was 
engaged- to assist Senior Management 
with the development of a functional 
plan. The plan would determine the 
scope and range of services Lehigh 
Valley Hospital could expect to provide 
over the next 10 years and the type of 
facilities which would be needed to 
accommodate those services. 
The major recommendations called for 
the redesign of the process by which 
both out-patient and inpatient services 
are delivered. Service delivery will bt. 
driven by a concept called "The Ideal 
Patient Encounter" which attempts to 
maximize convenience to the patient 
and maximize the clinical encounter. 
It is believed that through this service 
delivery redesign, the hospital and its 
medical staff will achieve operating 
efficiencies critical to remaining 
competitive in health services delivery 
-- efficiencies driven by the need to 
reduce costs and improve service 
delivery in the light of increasing 
pressures from purchasers of health 
services, i.e., managed care 
companies, insurers, business and 
industry, and government purchasers of 
care. 
Continued on Page 5 
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The plan also outlined the needs to add 
additional square footage at the Cedar 
Crest site not only for redesigned 
outpatient services but for the final 
consolidation of OB/GYN and Mental 
Health Services, and the return of 
ambulatory surgery to Cedar Crest. 
Tentative plans call for the additional 
construction of approximately 150,000 
square feet for ambulatory diagnostics, 
ambulatory surgery, emergency and 
diagnostic center growth and the 
relocation of Women's and Mental 
Health Services. An additional 
renovation of 58,000 square feet was 
recommended for emergency and 
diagnostics, a patient access center, 
cardiac diagnostics and 
angiography /CT suites. 
Several levels of underground parking 
were also recommended in a footprint 
that would extend out from the 
northeast comer of the hospital and up 
to but not including the 1210 building. 
Total project cost of this next phase of 
construction, expected to be completed 
in 1997/98, is currently estimated to be 
$58 million. It has previously been 
estimated that annual operating 
efficiencies achieved by the complete 
inpatient consolidation could be in the 
range of $28 million. 
Discussion on Saturday morning 
provided attendees with an update of 
the Physician Hospital Organization 
and several of its components, the 
Independent Practice Organization and 
the Lehigh Valley Physicians 
organization. Board members 
discussed the logic of these 
organizations and how they would 
better position the organization to 
respond to the changes brought on by 
managed care. They also learned of 
other activity in the service area by 
various physician groups and hospitals 
in response to the changing market. 
The meeting closed with a discussion 
of loyalty between the Board and the 
medical staff and concluded that a 
statement from the Board outlining its 
expectations of the medical staff and 
the expectation medical staff members 
could have of the Board, should be 
developed. 
The next steps in this process will 
involve review of the functional . 
planning recommendations at the July 
6 Board of Trustees meeting, 
distribution of the decision making 
matrix to physicians and management 
and further development of the PHO. 
All medical staff members are 
encouraged to direct any questions to 
members of the Senior Management 
Council who represent your specialty 
or plan to attend your regularly 
_scheduled department meetings. 
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Two Management Appointments Announced 
Elliot I. Sussman, M.D., President and 
Chief Operating Officer, recently 
announced the appointments of James 
B. Burke as Vice President of Site 
Operations for 17th & Chew, effective 
June 1, and Louis L. Uebhaber to· the 
position of Chief Operating Officer. 
Mr. Liebhaber will assume his duties 
on July 11. 
In his new position, Mr. Burke will be 
responsible for all day-to-day activities, 
including the transition of all clinical 
services at 17th & Chew. He will 
direct the consolidation of acute care 
inpatient pediatrics and 
medical/ surgical services and help to 
implement and operate the hospital-
based skilled nursing facility and 
interim ambulatory surgery at the site. 
He will report directly to the chief 
operating officer. 
Prior to joining Lehigh Valley 
Hospital, Mr. Burke was director of 
program and operations analysis for the 
Hospital of the University of 
Pennsylvania since 1986, where he 
directed a variety of activities ranging 
from management engineering projects 
to programmatic business planning. 
Mr. Burke began his career in 1981 as 
a management engineer for Frankford 
Hospital in Philadelphia, and in 1985 
was named corporate management 
engineer for Universal Health Systems, 
Inc., in King of Prussia. 
A 1979 graduate of the University of 
Pennsylvania with a B.A. in 
Economics, Mr. Burke also holds a 
masters degree in business 
administration from Drexel University. 
He and his wife, Kathleen, recently 
became· the parents of triplets, James, 
Christopher, and Elizabeth. 
With over 20 years of health care 
management experience, Mr. 
Liebhaber has strong skills in team 
building, resource management, 
physician relations, managed care, and 
staff and management communications. 
As the Chief Operating Officer, he will 
manage daily hospital operations. He 
will work closely with administrative 
and management staffs, guide, direct, 
and assure the efficient and effective 
operation of hospital departments, 
systems, programs, projects, and 
patient care and support staffs. 
Currently, Mr. Liebhaber is vice 
president for operations at Beth Israel 
Medical Center (BIMC) in New Yorlr 
City with responsibility for the daily 
operations of the facility. He began at 
BIMC in 1983 as assistant director for 
operations. The system includes Beth 
Israel Medical Center, a 949-bed, full 
service, teaching hospital affiliated 
with Mt. Sinai School of Medicine; 
Beth Israel Hospital-North, a 229-bed 
acute care hospital; Beth Israel, a 245-
bed long term care facility in 
Westchester County; the Phillips Beth 
Israel School of Nursing; and New 
York Health Care, a comprehensive, 
ambulatory care facility. 
Some of Mr. Liebhaber's professional 
accomplishments during his tenure at 
BIMC include implementation of a 
clinical lab commercial joint venture; 
establishment of a designated AIDS 
Continued on Page 7 
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center; d~velopment and 
implementation of extensive home 
infusion therapy program; expansion of 
pre-admission testing; implementation 
of a program to reduce obstetrical 
length of stay; development of a 
concurrent mortality review and quality 
assurance program; and participation in 
Beth Israel's $54 million modernization 
and expansion program. 
Mr. Liebhaber earned his B.A. at 
Brandeis University in 1972. He 
received his M.B.A. with a 
concentration in health care 
management from Boston University in 
1975. He is married and has two 
children, aged eight and ten. His wife, 
Barbara, is an accomplished musician · 
and teaches part-time. 
Saturday Transfers to Good Shepherd Rehab Hospital 
Good Shepherd Rehabilitation Hospital 
will now accept transfers on Saturdays. 
In April, Good Shepherd Rehabilitation 
Hospital began accepting Saturday 
transfers of stable orthopedic patients. 
They have since expanded to now 
accept strokes and amputees and will 
continue to evaluate and expand this 
service as the need expands. 
Key points to remember if you wish to 
transfer your patient on a Saturday 
include: 
• Patient must be medically 
stable. 
• All transfer orders must be 
complete and on the chart 
Friday. 
• Decision to transfer must be 
made Friday in order to get 
chart copied and arrange 
transportation. 
• Good Shepherd Rehabilitation 
Hospital has a limit of three 
patients they will accept on 
Saturday. 
• Transfer will occur between 
8:30 and 9:30 a.m. to allow 
patients to receive therapy at 
Good Shepherd Rehabilitation 
Hospital. 
If you have any questions or need more 
information, please contact Susan L. 
Lawrence, Director, Integrated Quality 
Assurance/Resource Utilization 
Management, at 402-2414. 
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Welcome, New Housestaff 
Please join the Office of Education in 
welcoming the 44 new housestaff 
beginning their resident education at 
Lehigh Valley Hospital the week of 
June 24. They are listed below, along 
with their dental, medical or 
osteopathic school. 
Colon and Rectal Surgery 
• JeffreyS. Aronoff, M.D., University of 
Medicine and Dentistry of New Jersey 
• Paul A. Lucha, D.O., University of 
Medicine and Dentistry of New Jersey 
Dentistry 
• Karen M. Bond, D.D.S., University of 
Maryland 
• John W. Capparell, D.M.D., Temple 
University School of Dentistry 
General Surgery 
• William J. Edmiston, Jr., M.D., Ross 
University School of Medicine 
• Edward J. Frick, Jr., M.D., Temple 
University 
• EllenA. Janetzke, M.D., Wayne State 
University 
• Paula A. Lundgren, M.D~, Jefferson 
Medical College 
• Robert W. Watson ll, M.D., University of 
Nevada Medical School 
• Stuart J. White, M.D., University of 
Medicine and Dentistry of New Jersey 
lnte17UJI Medicine 
• Sanjay Arora, M.D., HalmMIIDD University 
• Anjam N. Bhatti, M.D., Mebany Medical 
School 
• Armando A. DeFeria, M.D., Ross 
University 
• Jeaninne M. Einfalt, D.O., Philadelphia 
College of Osteopathic Medicine 
• Jeffrey D. Gould, M.D., Habnemann 
University 
• Dawn M. Kemledy, D.O., Philadelphia 
Collcp of Osteopathic Medicine 
• Andras Koller, M.D., Ushgorod State 
University 
• Anthony V. Matejicka U, D.O., Philadelphia 
College of Osteopathic Medicine 
• ~id Mushtaq, M.D., King Edward 
Medical College 
• Sethuraman Muthiah, M.D., MRCP-Ireland 
• Malcolm C. Townsley, M.D., Georgetown 
University School of Medicine 
Obstetrics and Gynecology 
• Deborah A. Lebrich, M.D., Medical 
College of Pennsylvania 
• Bani A. Sarma, M.D., Temple University 
• Rose Mary Sobel, M.D., Jefferson Medical 
College 
• Aline-Marie Tomlinson-Jones, M.D., 
University of Medicine and Dentistry of New 
Jersey 
Osteopllthic Emergency Medicine 
• Tncy C. Barber, D.O., University of 
Health Science, Mi880uri 
.• Gary M. Bonfante, D.O., Philadelphia 
College of Osteopathic Medicine 
• Heath A. Jolliff, D.O., Ohio University 
College of Osteopathic Medicine 
• Kevin J. O'Gara, D.O., University of 
Health Science, Mi880uri 
Pathology 
• Eugene Alexandrin, M.D., Kbarkov Medical 
Institute 
Plastic Surgery 
• Katheryn M. Warren, M.D., University of 
CoDDeCticut Health Center 
Continued on Page 9 
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Radiology 
• Rick G. Clark, D.O., Philadelphia College 
of Osteopathic Medicine 
• SUZ81U1e C. Moffit, D.O., Michipn S~ 
University 
• John J. Zoshak:, D.O., Philadelphia Colleae 
of Osteopathic Medicine 
Trauma I Surgical Critical Care 
• Richard A. Damian, M.D., State University 
of New York Health Science Center at 
Syracuse 
TransitioiUll Year 
• Craig K. Depoe, M.D., Hahnemann 
University 
• Ou:istine E. Hinke, M.D., New York 
Medical Collep 
• Robert C. Moraan, M.D., HabMID!IDD 
University 
• Yong T. Oh, M.D., HahnoiDIIIIl Uaiversity 
• Todd A. Phillips, M.D., Loma Linda 
Uaiversity School of Medicine 
• Elmer G. Pinzon, M.D., Hahnemann 
Uaiversity 
• John L. Poag ll, M.D., Medical College of 
Georgia 
• Charles M. Terry, M.D., HahnemaDn 
University 
.• Joseph F. Waldner, M.D., Habnemann 
University 
Lehigh Valley Hospital to Participate in Clinical Trial 
Lehigh Valley Hospital has been 
accepted as one of only 200 sites to 
participate in the Antihypertensive and 
Lipid-Lowering Therapy to Prevent 
Heart Attack Trial (ALLHAT) 
sponsored by the National Heart, 
Lung, and Blood Institute. Nelson P. 
Kopyt, D.O., nephrologist, will serve 
as the physician investigator for the 
hospital. 
At least 150 high-risk hypertensive 
patients will be recruited to participate 
in the trial. Candidates will include 
men and women over age 60 with high 
blood pressure and at least one other 
risk factor of heart disease, e.g., type 
11 diabetes, hx. of CABG, HDL 
< 35mgldl, and documented ASCVD 
or carotid disease not requiring 
surgery. Enrollment will begin this 
fall. 
For more information, contact Dr. 
Kopyt at 432-8488 or Mary Ann 
Gergits, Research Nurse Coordinator, 
Department of Medicine, at 402-0544. 
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Helpful Hints 
Coding 
The following continues our list of 
common conditions which are not 







Congestive Heart Failure (CHF) 
Compensated 
Hypotension 
Accurate documentation enables 
accurate data collection and optimal 
reimbursement. 
Thank you for your cooperation in this 
matter. 
One Office Manager's System of Checks and 
Balances by Eva Ritter Levitt 
Every office needs a system of checks 
and balances for accuracy and office 
security. There are six key areas to 
consider: patient registration at the 
front desk, patient discharge with 
check out receptionist, checks or cash 
that arrive by mail or "walk ins," 
hospital billing, payroll, and payment 
of invoices. 
• When a patient registers for an 
appointment, he/she should have a 
router (superbill) attached to the chart. 
The router should have a number, the 
date, and the patient's name. The 
receptionist needs to check this 
· information and list the previous 
balance on the router. 
• At the conclusion of the visit, the 
doctor must mark the router with the 
diagnosis, and check the appropriate 
CPT code(s) to be charged. The 
patient proceeds to the check out 
receptionist who enters the charges into 
the computer and collects payment if 
the patient is a self-pay or if there is a 
co-pay or deductible and refers the 
other charges to insurance. The check 
out receptionist places the payment in a 
bank envelope and completes the 
bottom of the router with the amount 
collected and what was billed to the 
insurance company. The patient is 
given a copy of the superbill or a 
computer equivalent. At the end of the 
day' the check out person will count up 
all the routers and fill out a cover sheet 
where she marks the number of 
patients seen that day and the number 
of routers entered. The two numbers 
should match. She runs a total of the 
Continued on Page 1 1 
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checks and cash received. This packet 
is then given to a person in the billing 
department who must verify that a 
charge was generated for each patient 
listed in the appointment book. If a 
patient's visit was cancelled, the router 
should appear in the packet with 
"cancelled" written on it. Thus, if 20 
patients are on the daily list, there 
must be 20 routers at the end of the 
day. 
• Hospital charges should be entered 
by the billing section. The doctors 
should provide the hospital charges to 
the billing section as soon as each case 
is completed, thus enabling the billing 
staff to process the bills in a timely 
manner to the proper sources. The 
billing section should maintain a record 
of all hospital consults listed and check 
the charges against this list to verify 
that every inpatient gets billed. 
• Checks received in the daily mail 
must be opened by a person different 
from the one who posts the payments 
in the computer or on the charge cards. 
Ideally, this individual should make a 
list of the patient name and the amount 
received. The office manager should 
review the incoming checks to verify 
which accounts are being paid and 
which accounts need to be reviewed. 
The checks are then given to a member 
of the billing staff, preferably an 
individual other than the one who 
enters the hospital charges. 
• The daily deposit should be 
processed by someone in the billing 
section. This individual must collate 
the payments from the discharge 
receptionist and the daily mail. All 
checks should be copied and stapled to 
a copy of the deposit slip as supporting 
documentation in the event that 
questions arise regarding the checks. 
This individual must confirm that each 
check received by mail has been 
posted. Verification can be made 
against the list that was prepared by the 
receptionist who opened the checks. 
The totalled checks and cash must 
equal the total payments for the day 
according to the computer or the peg 
board sheet. Ideally, the deposit 
should be reviewed and made by one 
()f the doctors on a daily basis. 
• A part-time bookkeeper pays all 
invoices with checks which are signed 
by one of the doctors or the office. 
manager. Payroll is done by a 
computerized payroll service which 
provides a print-out of cumulative total 
of salaries and deductions for each pay 
period. 
In summary, for office accuracy and 
security, it is important to have several 
distinct members of the staff involved 
in the handling of the monies generated 
by a practice and in the payment of 
bills. A system of checks and balances 
with office manager and physician 
oversight shoUld prevent problems 
from arising. 
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PHAMIS LastWord Training Schedule for Physicians 
Following is a schedule of classes to be 
held by Information Services regarding 
PHAMIS LastWord training for 
physicians, residents, and allied health 
personnel. 
Tuesday, June 21 - 5 to 7 p.m. 
Thursday, July 7- 6 to 8 a.m. 
Tuesday, July 12- 1 to 3 p.m. 
Wednesday, July 20- 5 to 7 p.m. 
Congratulations! 
Wayne E. Dubov, M.D., physiatrist, 
successfully passed the required 
examination and has now beCome a 
Diplomate of the American Board of 
Electrodiagnostic Medicine. 
Peter A. Keblish, M.D., chief, 
Division of Orthopedic Surgery, has 
accepted the position of Review Editor 
for the Joui'IUll of OrthoptUdic 
RheumlltOlogy. Manuscripts will be 
sent to Dr. Keblish for his expert 
orthopedic evaluation and comments. 
David Prager, M.D., hematologist/ 
oncologist, and Medical Director, John 
and Dorothy Morgan Cancer Center, 
was recently elected to the Board of 
Directors of the American Society of 
Clinical Oncology. In addition, he was 
also appointed to the Executive 
Committee of the National Surgical 
Adjuvant Breast and Bowel Project. 
Lester Rosen, M.D., colon and rectal 
surgeon, was elected to the Executive 
Council of the American Society of 
Colon and Rectal Surgery during the 
Classes will be held on the first floor 
of the School of Nursing at 17th &. 
Chew. 
To register for a class, or if you have 
any questions, please contact Diann 
~rey in Information Services at 
402-1404. 
society's 93rd annual convention, May 
8-13. During this conference, he 
presented the current status of practice 
parameters for colon and rectal surgery 
at the State of the Society symposium. 
Dr. Rosen also served on an expert 
panel for clinical case presentations. 
John J. Stasik, Jr., M.D., chief, 
Division of Colon/Rectal Surgery, has 
_been appointed to the Quality 
Improvement Committee of the 
Community Choice health care plan. 
He was nominated for this appointment 
by Lehigh County Medical Society to 
represent specialty services. He is the 
only surgical specialist on this 
committee. 
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Publications, Papers and Presentations 
Thomas B. Dickson, M.D., and 
Thomas D. Meade, M.D., orthopedic 
surgeons, were presenters at the Sports 
Advisory Board Conference for Senior 
High Athletes and their Coaches at 
Lehigh University on April 27. The 
program was sponsored by the Alcohol 
and Drug Dependence Center - Lehigh 
Valley. Dr. Dickson's presentation 
was Nutrition and Steroids; Dr. 
Meade presented Sports Injury 
Prevention. 
Jane Dorval, M.D., chief, Division of 
Physical Medicine and Rehabilitation, 
was an invited speaker at Prevention 
of Secondary Conditions Associated 
with Spina Bifida and Cerebral· 
Palsy, a symposium sponsored by the 
Spina Bifida Association of America, 
United Cerebral Palsy Associations, 
Inc., Centers for Disease Control and 
Prevention, and the National Institutes 
for Health, held in Washington, DC, 
on February 19. 
Dr. Dorval also presented Promoting 
Independence in Children with 
Disabilities at the Seventh World 
Congress of the International 
Rehabilitation Association meeting held 
in Washington, DC, in April. 
Jason Green, M.D., Colon/Rectal 
Surgery Resident from 1992-93, 
presented Transanal Diskectomy for 
Cure of Rectal Adenocarcinoma: Is 
Clinical Judgment Accurate? at the 
93rd annual convention of the 
American Society of Colon and Rectal 
Surgeons in Orlando, Fla. This paper 
reviewed the outcome of 104 patients 
with carcinoma of the rectum who 
underwent transanal diskectomy with 
attempt to cure. Robert D. Riether, 
M.D., colon and rectal surgeon, is the 
senior author of the paper which will 
be submitted to Diseases of the Colon 
and Rectum for publication. 
Houshang G. Hamadani, M.D., 
psychiatrist, presented a paper at the 
American Psychiatric Association 
Annual Meeting in Philadelphia on 
May 24. The title of the paper is 
Actions and Reactions of the Host 
Country, Part of the Compentent on 
Opportunities in International 
Psychiatric Exchanges. 
Thomas D. Meade, M.D., orthopedic 
surgeon, is spearheading a Shoulder 
Improvement Day in cooperation with 
the Allentown Sports Medicine and 
Human Performance Center and 
Affinity. This is a free public service 
offering evaluations from orthopedic 
surgeons, physical therapists, exercise 
physiologists, strength trainers, and 
sports specific coaches to any 
individual interested in maximizing 
their shoulder function at work and in 
sports. The program will be held on 
Saturday, June 18, from 9 a.m. to 
noon, at the Allentown Sports 
Medicine and Human Performance 
Center in the lower level of 1243 S. 
Cedar Crest Boulevard, Allentown. 
David P. Steed, D.P.M., chief, 
Section of Podiatry, and Scott J. 
Upkin, D.P .M., podiatrist, co-
authored A Human Cultured Dermal 
Replacement for the Treatment of 
Diabetic Foot Ulcers. This was 
presented in April at the Seventh 
Annual Symposium on Advanced 





Upcoming Seminars, Conferences and Meetings 
Department of Pediatrics 
Update on Epilepsy will be presented 
by Martha A. Lusser, M.D., chief, 
Division of Pediatric Neurology, on 
Friday, June 24, beginning at noon in 
the Auditorium of Lehigh Valley 
Hospital, 17th & Chew. 
• For Sale or Lease -- Springhouse 
Professional Center, 1575 Pond Road. Ideal 
for physician's office. Approximately 1,000 
sq. ft. 
• For Sales or Lease -- Medical/Professional 
three-story office building at 1730 Chew 
Street, Allentown. Excellent condition with 
recent renovations. Approximately 6,800 
sq. ft. for single or multiple specialty 
practice. Includes long-term parking lease 
at Fairgrounds. Potential telephone and 
dictations systems. 
• For Sale -- Office building at Northeast 
corner of 19th and Turner Streets in 
Allentown. Upper level - 2,400 + sq. ft., 
large waiting room, two large consultation 
rooms, five exam rooms, etc. Lower level-
2,300+ SQ; ft. Parking lot for 16 cars. 
• For Lease -- Office to sublet on Monday, 
Tuesday, Thursday, and Friday. 950 sq. ft. 
Common waiting area. Lakeside 
Professional Building, Quakertown. 
• For Lease -- Large, newly remodeled, 
completely furnished medical office space 
available for subleasing/time share at Cedar 
Crest Professional Park. Top of the line 
telephone system. Transcription and 
computer system with electronic billing 
available 
• For Lease -- Slots are currently available 
for the Brown Bag suite at Kutztown 
Professional Center. Ideal for satellite 
location. 
For more information, contact Beverly 
Humphrey in the Department of 
Pediatrics at 402-2410. 
• For Lease - Several time slots are 
available in the medical office building on 
the campus of Gnaden Huetten Memorial 
Hospital in Lehighton. 
• For Lease -- Medical-professional office 
space located on Route 222 in Wescosville. 
Two 1 ,000 sq. ft. offices available or 
combine to form larger suite. 
• For Lease-- Medical office space located 
in Peachtree Office Plaza in Whitehall. Ont" 
suite with 1 ,500 sq. ft. (unfinished -
allowance available), and one 1,000 sq. ft. 
finished suite. 
• For Lease -- Specialty practice time-share 
space available in a comprehensive health 
care facility. Riverside Professional Center, 
4019 Wynnewood Drive, Laurys Station. 
Half- or full-day slots immediately available. 
• For Lease -- Professional office space 
available in an established psychology and 
psychotherapy practice at 45 N. 13th 
Street, Allentown. Large, warm Victorian 
building in a relaxed atmosphere. Secretary 
and billing available and included in some 
leases. Furnished or unfurnished full offices 
and sublets available. Utilities included. 
For more information or for assistance in 
finding appropriate office space to meet 
your needs, contact Joe Pilla, Physician 
Relations Rep, at 402-9856. 
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WHO'S NEW 
The Who's New section of Medical 
Stqff Progress Notes contains an 
update of new appointments, address 
changes, newly approved privileges, 
etc. Please remember that each 
department or unit is responsible for 
updating its directory, rolodexes and 
approved privilege rosters. ' 
Medical Staff 
Appointments 
Nicholas C. Kyriazi, MD 
Family Pediatricians, Inc. 
(Dennis W. Kean, MD) 
Allentown Medical Center 
401 N. 17th Street, #109 
Allentown, PA 18104-6804 
(610) 435-6352 
Department of Pediatrics 
Division of General Pediatrics 
Provisional Active 
Richard J. Morse, MD 
Lehigh Valley Pediatric Associates 
(Oscar A. Morffi, MD) 
Allentown Medical Center 
401 N. 17th Street, #307 
Allentown, PA 18104-5051 
(610) 434-2162 
Department of Pediatrics 
Division of General Pediatrics 
Provisional Courtesy 
Ralph E. Stolz, DO 
(solo) 
Doctors Clinic 
555 Harrison Street 
Emmaus, PA 18049-2339 
(610) 967-3115 
Department of Family Practice 
Provisional Active 
Additional Privileges 
Peter J. Barbour, MD 
Department of Medicine 
Division of Neurosciences 
(Lehigh Neurology) 
Active 
Treatment of Dystonia with Botulinum 
Toxin 
Mario A. Candal, MD 
Department of Obstetrics and 
Gynecology 
Division of Obstetrics/Gynecology 
Section of Benign Gynecology 
Courtesy 
Obstetrical Privileges 
Robert J. Coni, DO 
Department of Medicine 
Division of Neurosciences 
(Neurological Services) 
Active 
Treatment of Dystonia with Botulinum 
Toxin 
John D. Farrell, MD 
Department of Family Practice 
(Parkland Family Health Center) 
Active 
Emergency Medicine Privileges 
Arthur E. Fetzer, MD 
Department of Surgery 
Division of Urology 
Active 
Collagen Implantation Privileges 
HughS. Gallagher, MD 
Department of Medicine 
Division of Cardiology 
(Cardiovascular Associates) 
Active 
Stent Placement Privileges 
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Linda L. Lapos, MD 
Department of Surgery 




Richard M. Liebennan, MD 
Department of Surgery 
Division of Urology 
(solo) 
Active 
Collagen Implan~tion Privileges 
James L. McCuUoup, MD 
Department of Surgery 
Division of Vascular Surgery 
(Peripheral Vascular Surgeons) 
Active 
Placement of Transluminal Peripheral 
Arterial Stents 
Craig R. Reckard, MD 
Department of Surgery 
Division of General Surgery 




Change of Status 
Judith N. Barrett, MD 
Department of Family Practice 
(solo) 
From Courtesy to Provisional Active 
J. Grea Brady, DO 
Department of Medicine 
Division of Dermatology 
(Stephen M. Purcell, DO) 
From Provisional Consulting to 
Provisional Active 
Mario A. Candal, MD 
Department of Obstetrics and 
Gynecology 
Division of Obstetrics/Gynecology 
Section of Benign Gynecology 
(Hospital) 
From Courtesy to Provisional Active 
James T. Dorsey, MD 
Department of Obstetrics and 
Gynecology 
Division of Gynecology 
Section of Benign Gynecology 
From Active to Honorary 
Bruce R. Ganey, DPM 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Podiatry 
(solo) 
From Courtesy to Provisional Active 
$baron M. GausJ.in&, MD 
Department of Pediatrics 
Division of General Pediatrics 
(Children •a HealthCare) 
From Active to Courtesy 
Dieter W. Leipert, DDS 
Department of Surgery 
Division of Oral and Maxillofacial 
Surgery 
(solo) 
From Courtesy to Provisional Active 
Nancy A. Mao, MD 
Department of Medicine 
Division of General Internal Medicine 
(Sam Bub, MD) 
From Courtesy to Provisional Active 
Russell B. Puschak, MD 
Department of Pediatrics 
Division of General Pediatrics 
(solo) 
From Active to Emeritus Active 
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Thomas Renaldo, DO 
Department of Family Practice 
(MacArthur Medical Center) 
From Courtesy to Provisional Active 
David M. Stein, DO 
Department of Medicine 
Division of General Internal Medicine 
(solo) 
From Courtesy to Provisional Active 
Larry W. Todd, DO 
Department of Family Practice 
(MacArthur Medical Center) 
From Courtesy to Provisional Active 
Gregory Tomcho, DO 
Department of Family Practice 
(MacArthur Medical Center) 
From Courtesy to Provisional Active 
Andrea Waxman, :MD 
Department of Obstetrics and 
Gynecology 
Division of Obstetrics/Gynecology 
Section of Benign Gynecology 
(Mary T. Zygmunt, DO) 
From Courtesy to Provisional Active 
Mary T. Zyamunt, DO 
Department of Obstetrics and 
Gynecology 
Division of Obstetrics/Gynecology 
Section of Benign Gynecology 
(with Andrea Waxman, MD) 
From Courtesy to Provisional Active 
Department of Surgery 
Division Reassignments 
(Reassignment of membership in the 
Department of Surgery - Division of 
General Surgery as a result of a 
revision to the Medical Staff Bylaws in 
which the section of Surgical Oncology 
has been deleted.) 
Division ~f General Suraery 
Richard C. Boorse, MD 
George S. Boyer, MD 
William W. Frailey, MD 
Milton J. Friedberg, MD 
Mark A. Gittleman,· MD 
George W. Hartzell, MD 
Ismail Nabati, MD 
;peter F. Rovito, MD 
Barry H. Slaven, MD 
Division of General Suqery/Trauma 
Charles J. Scagliotti, MD 
Kamalesh T. Shah, MD 
Gerald P. Sherwin, MD 
Division of General Suraery, Section 
of Critical Care 
Nora A. Suggs, MD 
Douglas R. Trostle, MD 
Division of General Suqery/Trauma, 
Section of Critical Care 
Kevin E. Glancy, MD 
·Department of Obstetrics and 
Gynecology Division/Section 
Reassignments 
(Reassignment of membership in the 
Department of Obstetrics and 
Gynecology as a result of a revision to 
the Medical Staff Bylaws in which 
various Division and Section titles have 
been renamed.) 
Division of Gynecology, Section of 
Gynecologic Oncology 
Gazi Abdulhay, MD 
Sergio Perticucci, MD · 
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Division of Gynecology, Section of 
Pelvic Reconstructive Surgery 
Vincent R. Lucente, MD 
Division of Gynecology, Section of 
Reproductive Endocrinology & 
Infertility 
Bruce I. Rose, MD 
Sta.cie I. Weil, MD 
Division of Obstetrics, Section of 
Maternal-Fetal Medicine 
Robert 0. Atlas, MD 
James Balducci, MD 
Anthony Johnson, DO 
Division of Primary Obstetrics and 
Gynecology 
Lisa Baker-Vaughn, MD 
Gail E. Burgey, MD 
Mario A. Candal, MD 
Sungji Chai, MD 
Robert V. Cummings, MD 
James T. Dorsey, MD 
Henry H. Fetterman, MD 
Beth A. Folio, MD 
Lyster M. Gearhart, MD 
Edward E. Geosits, DO 
Larry R. Glazerman, MD 
T. A. Gopal, MD 
Joseph N. Greybush, MD 
Zirka M. Halibey, MD 
Thomas A. Hutchinson, MD 
EarlS. Jefferis, Jr., MD 
Ellen M. Joyce, MD 
Bruce M. Kaufmann, MD 
Stephen K. Klasko, MD 
Donald B. Kopenhaver, MD 
John B. Kucharczuk, MD 
Carl A. Lam, MD 
Chong S. Lee, MD 
David Lezinsky, DO 
Sheldon H. Linn, MD 
Howard M. Listwa, DO 
Gene W. Miller, DO 
Joseph A. Miller, MD 
Ernest Y. Normington ll, MD 
MichaelS. Patriarco, DO 
Gregory J. Radio, MD 
Charles W. Reninger, MD 
Bruce M. Rodenberger, MD 
Daniel M. Schwartzman, MD 
GeorgeS. Smith, MD 
Stanley Snyder, MD 
M. Bruce Viechnicki, MD 
Michael Vigilante, MD 
Andrea Waxman, MD 
Concepcion T. Yen, MD 
Mary T. Zygmunt, DO 
Address Changes 
Elizabeth Knapper, MD 
2895 Hamilton Blvd. 
Allentown, PA 18104 
(Effective 7/1/94) 
Dominic P. IAI, DDS 
6505 Route 309 
New Tripoli, PA 18066 
(610) 298-8805 
Richard J. Strisofsky, DMD 
127 Bridge Street 
Catasauqua, PA 18032 
(Effective 6/27/94) 
Baqamin Weinberaer, DMD 
Springhouse Oral Surgery 
1575 Pond Road 
Suite 204 
Allentown, PA 18104-2254 
(610) 366-9616 
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Practice Name Change 
The practice of Stephen M. Purcell, 
DO, and I. Greg Brady, DO, will now 
be known as Advanced Dermatology 
and Skin Cancer Center. 
Practice Change 
Marc W. Levin, MD, has joined 
Advanced Dermatology and Skin 
Cancer Center (Stephen M. Purcell, 
DO, and I. Greg Brady, DO) 
Unit Director Appointment 
Michael Pasquale, MD 
Medical Director 
Transitional Trauma Unit 
Death 
Guy L. Kratzer, MD 
Department of Surgery 





Kathleen A. Leh, RN 
Physician Extender 
Professional - RN 
(Dr. Subzposh) 
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Does not apply 
tome 
1 
Physician Well-Being Group 
Stress Check 
John C. Turoczi, Ed.D., FacDitator 
Take a few minutes to check your stress and bum-out level. 
Physician Stress Inventory (May and Revicld) 





1. I am no longer the "contributor" I used to be .....•.•..•....•.................. 1 2 3 4 
2. My initial expectations of my job 111e not being realized .•..•.••..••.••.•..•.•.••• 1 2 3 4 
3. My productivity has decreased .. ~ ........•...•.••.....•••....•........... 1 2 3 4 
4. I am less content with myself •..•...........•..•..•.•.....•.........•.... 1 2 3-4 
5. I often find myself feeling resentful, disenchanted, bored, or disco1111l8ed • . . • . • • • • . . . • • . . . 1 2 3 4 
6. Colleagues at work do not contribute their fair sbare • • • • • • • • • • • • • • • • • • • • • • • . • • • • • 1 2 3 4 
7. Work interferes with family life . . . . . . . . . . . • . . . . . . . . . . • . . . . . . . . . . . . . . • . . . . 1 2 3 4 
8. My professional growth and skills 111e stagnating • . . . . . . . . . . . . . . • . • . . . • . . . . . . . . . . 1 2 3 4 
9. My preoccupation with work IDikes it bard to disengage from the job at home . . . . . . . . . . . . . 1 2 3 4 
10. I am more edgy than I used to be ..........••.•..•.••••..•................ 1 2 3 4 
11. It seems like I just cannot get the recognition I feel that I deserve • . • . . . . . . . . . . . . . . . . . . 1 2 3 4 
12. I feel guilty when I caunot completely understand my patieots or clieots .•.•............. 1 2 3 4 
13. It seems like I have very little power to control the things that happen' to me . • . • . . . . . . . . . . 1 2 3 4 
14. I am working harder but getting less done • . . . . • • . . . • • . • . . • . • . . . . . . . . . . . . . . , . . 1 2 3 4 
15. I often feel that others are out to •screw• me • . • • • • • • • • . . . • • • • • . • . . • • . . . . . . . . . . 1 2 3 4 
16. Things of minor relevance now make me angry and frustrated •••••••••.••••..••.••.• 1 2 3 4 
17. I often arrive late for work • . . . . . . . . . . . . • • • . . • • • • . • • . • . . . . . . . . . . . . . . . . . . 1 2 3 4 
18. I occasionally hide in my office in order to shut out others . . . . . . . . . . . . . . . . . . . . . . . . . 1 2 3 4 
19. Arguments at home with spouse, children or others close to me have increaaed recently . . . . . . . 1 2 3 4 
20. I daydream more at work than I used to • • . • . . • . • • . • • . . . . . • . . . . . . . . . . . . . . . . . . 1 2 3 4 
21. My responsibilities 111e much different than I had anticipated •• ·. • • . . . • • . . . . . . . . . . . . . . 1 2 3 4 
22. Support for my contribution at work has been consistently lacking . . . . . • . . . . . . . . . . . . . . . 1 2 3 4 
Interpretation: 
Less than 42 
42-60 
Greater than 60 
Total the number of points. 
- Below average stress rating 
- Average stress rating 
- Above average stress rating 
Participation in the Weii-Beina Group: 
Less than 42 - Share with your colleagues how you do it! 
TOTAL SCORE 
42-60 - Share your coping strategies and do aome preventative work. 
Greater than 60 - Perhaps you need some support, new coping and stress redUcers. 
Research indicates that one of the best stress relievers for physicians is a peer support group. The next meeting 
of the Physician Well-Being Group open to new members is August 8. For more information, contact John C. 
Turoczi, Ed. D., group facilitator, at 481-9161. 
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Cedar Crest & I-7H 
Post ( )ffice Box 6H9 
Allentown, Pennsylvania I HI 05-15 56 
HEALTH NE1WORK 
lABORATORIES 
A Service of ILHU?H VAJ..LE'V June, 1994 
HtJSPfi:U. 
Dr. Doctor: 
The Clinical Laboratory has responded to an interest voiced by some of our 
Medical Staff for a service enhancement related to result reporting i.e., 
faxed reporting. We have been working closely with Hospital Information 
Services to complete this task and are pleased to announce we have been 
successful in passing clinical lab results from the Lab computer system 
(Sunquest) to the Tandem platform and then from there to fax machines located 
in physician offices. Pathology and Cytology reports are not available via 
this method however they can be faxed utilizing different mechanisms. 
We are now at the juncture in this project where we need to assess your 
interest and willingness in using Jthese electronic reporting capabilities. 
Please understand that the report you receive via fax would be your only 
copy. To assist you in this decision ~recess we have created a list of 
benefits and considerations (see back) . 
Please .indicate whether you would use this service or not by: 
• checking a box or boxes below 
• signing and returning this letter to Sharon L. Boley, 
Lab Administration ~ 17 site by July 15, 1994 
The results of this survey will help us determine the future of this project, 
i.e. move forward to implementation, table for future consideration, or drop 
the project. 
Thank you. 
Sharon L. Boley Jane E. Erdman 
Manager, Peripheral & Ancillary Sites 
Lab Admin 17; Ext. 2552 
Manager, Lab Information 






Yes I would use the clinical lab faxing service and I 
understand it is the only copy of the report I would receive. 
Yes I would use the pathology faxing service and I understand 
it is the only copy of the report I would receive. 
Yes I would use the cytology faxing service and I understand 
it is the only copy of the report I would receive. 





• faster turn- • the faxed report around-time· for is your only 
results copy 
reporting---
faxed results • photocopying of available daily 0 faxed report I lS 
prior to 0900 necessary if 
plain copy fax 
not available I ln 
• no misdirected office mail 








A Service of lEHigtiVAILEY 
HOSPml.. 
Thyroid Definitions 
A number of questions have been 
asked as to what is the best thyroid test 
or combination of tests for screening 
and/or diagnosis of thyroid disease. 
Before answering these questions in the 
next newsletter we have described each 
test with a discussion if appropriate, of 
the methodology. A * precedes each 
test where a change has occurred that 
you may particularly want to review. 
T4 (Total Thyroxine.) is the standard 
screening test for thyroid function 
which helps to screen for any type of 
hypothyroidism or hyperthyroidism. It 
is elevated in pregnancy and estrogen 
therapy due to an increase in TBG 
(thyroid binding globulin). It is 
lowered in states of protein depletion 
and with Dilantin or Testosterone 
therapy. Assessment of TBG in 
combination with T4 yields a calculated 
T7 or Free Thyroxine Index which will 
be "normal" in the presence of non-
thyroidal conditions. 
*TBI (Thyroid Bindin& Index> is the 
T3RU (uptake) test. We prefer that 
you order this test as TBI and not 
T3RU, as T3RU is often translated into 
a T3 TIA (triiodothyronine). This test 
is an indirect measurement of TBG and 
its only use is for the assessment of the 
effects of protein binding of T4 in 
conjunction with the interpretation of 
the total T4 measurement. The T7 
calculation is the T4 result multiplied 
by this TBI percentage which 
compensates or corrects for variations 
in TBG. 
IBG (Thyroid Bindin& Globulin) can 
be measured directly by RIA as the. 
protein concentration in mg/dl. 
*TSH (Thyroid Stimulatin& Hormone.) 
is the single most important tool for 
the diagnosis of thyroid disorders. We 
offer the 3rd generation assay at a 
sensitivity of 0.01 mUlL. It exhibits 
no crossreactivity with the other 
glycoprotein hormones and is not 
affected by protein binding. We 
employ a chemiluminescent 
methodology which produces the high 
degree of sensitivity of this test. The 
3rd generation TSH test is used to 
monitor T4 replacement or suppressive 
therapy, to quantify TSH in the 
subnormal range and to distinguish 
hospitalized patients with NTI (non-
thyroid illness) from those with 
hyperthyroidism. It also can be 
utilized as a sensitive screening test for 
primary thyroid disorder. 
*Ef4 (Free T4) is the determination of 
the quantity of thyroxine in the blood 
not bound to protein. Only 0.1% of 
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the T4 is the free metabolically active 
hormone available to tissues with the 
rest bound to TGB, albumin and 
prealbumin. Actually the FT4 test 
could be a direct replacement for the 
TI calculation because it is unaffected 
by variations in serum T4 binding 
proteins. Until now, the FT4 test has 
been employed as a special 
confrrmation test because the direct 
equilibrium dialysis methodology was a 
2 day, labor intensive, costly test not 
suitable to automation. We are 
presently using a one-step, automated 
method which has been optimized to 
eliminate T4 binding to endogenous 
protein while leaving undisturbed the 
original equilibrium between the free 
and TBG bound T4. This FT4 test is 
used to distinguish euthyroi4 
hyperthyroximemia from 
hyperthyroidism or euthyroid 
hypothyroxinemia from hypothyroidism 
and to monitor thyroid function and 
replacement therapy in the setting of 
hypothalamic pituitary disease. 
T3 (Total triiodothyronine) is derived 
predominantly from the 
monodeiodination of thyroxine in 
peripheral tissues (80%). It is present 
in circulation at concentrations of only 
1% of the T4 level but is 10 times 
more active then T4 in binding to cell 
receptors. T3 also called T-3 RIA is a 
special test which helps in the 
diagnosis of thyroid disorders causing 
thyrotoxicosis. 
FT3 (Free Triiodothyronine) is the 
determination of the T3 hormone that 
is extensively not bound to circulating 
protein. Only the free hormone is 
available to actively bind to receptor 
sites. This test is quite expensive and 
time consuming and so infrequently 
required to make a diagnosis of thyroid 
dysfunction that we have made it non-
orderable except by special 
consultation. 
RT3 (Reverse triiodothyronine> is 
derived from the removal of an iodine 
molecule from T4 by the peripheral 
tissues. Whereas T3 is 3, 5 ,3' 
Triiodothyronine, the RT3 is 3, 3', 5' 
Triiodothyronine which is 
metabolically inactive. In non-
thyroidal illnesses the conversion of T4 
to T3 may be inhibited with a resulting 
increase in inactive RT3. This test can · 
help in the diagnosis of a low T3 
syndrome associated with non-thyroidal 
illness. 
Autoimmune-Thyroid disease is 
associated with a wide variety of 
heterogeneous thyroid-related 
antibodies. These include 
antimicrosomal antibodies, antithyroid 
peroxidase antibody and a variety of 
anti TSH receptor antibodies that maJ 
be stimulating or inhibitory. In this 
last category TSI (Thyroid Stimulating 
Immunoglobulin) is elevated in Graves 
disease. In general th~ antibody tests 
are used for the diagnosis of the 
different type of autoimmune thyroid 
diseases. 
Larry N. Merkle, M.D. 
Endocrinology/Metabolism 











What is an ethics 
consult 
S.Lammers 
1 Krank's Korner 
Anonymous 
Issues In Medical Ethics 
Editorial: 
T hanks to those who sent their comments in about Issues 1 and 2. They were gratefully received and will be used in future issues. In this Issues number 3, a panel of authors review the treannent ofJehovah's 'Witnesses in the hospital. It 
is anecdotally interesting that the trend of medical practice away from widespread use of 
transfusions has swept us nearer to the 'Wimesses, albeit for very different reasons. Some 
of the information gathered from the treannent of patients with this religious belief may 
in fact help treat others when transfusions are not an option for care, or under circum-
stances where transfusions become scarce ... In this issue also, a review of What an Ethics 
Consultion is. The committee has found there is still some confusion over when, and 
why and how one proceeds with such a consultation ... Finally, in this corner: the first in a 
series ofK.rank commentaries. We hope this continuing series will provide an outlet for 
those poor souls who have difficulty with the mainstream trends of medicine, prefering, 
for example, to call a doctor a doctor and a nurse a nurse, and not a preferred provider ... 
Look for upcoming topics in the "Issues": ETillCS OF TRANSPLANTATION; 
ETIDCS OF PAIN CONTROL; ETIDCS OF 'WITHDRAWING AND WITH-
HOLDING CARE. 
-ARae-Grant 
What Is An Ethics Consult? 
Members of the Ethics Committee have Include in the request the reasons why you 
observed that there is some confusion are asking for the consultation. (In other 
about the purpose of ethics consultations words, please do not only say, "Consult 
and what actually happens during these Ethics Committee.'') That request should 
consults. To help out, they have prepared be forwarded to the Critical Care Office 
the following question and answer format. (ext. 8450). The chair of the Ethics Com-
1. "Who can call an ethics consult? A mittee should be paged if there is no time-
physician can write a consultation request ly response to the original request. 
in the chart or a nurse can request a con- 3. 'Who does the ethics consulta-
sultation through their head nurse. tions? After the chair of the Ethics Com-
Patients may also request an ethics consul- mittee determines that the request is in 
tation through their physician, nurse or fact for an ethics consultation, an interdis-
the patient representative. . ciplinary team is called. The team is head-
2. How do I call an ethics consult? If ed by a physician and three to six members 
a physician, write a consultation request. Continued on Page 2 
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of the Ethics Committee join the team 
leader to evaluate the case. All team mem-
bers are volunteers. 
4. "What does the ethics consultation 
team do? This varies from case to case. 
Generally, they examine the chart, speak 
with nurses and physicians who have cared 
for the patient. If possible, they speak with 
the patient. Where required, they meet 
with the patient's fumily and others who 
may be empowered to speak fur the 
patient. 
Once they have gathered all the infOr-
mation they think necessary, the team 
meets privately to discuss the case. After 
discussion, the team usually makes recom-
mendations. The team leader writes a 
note to be placed temporarily in the 
patients chart. 
5. What if I disagree with the rec-
ommendation? This is only a recom-
mendation. Physicians have disagreed 
with ethics consultation recommendations 
in the past in this hospital. We are happy 
to report that this happens rarely, but it 
does happen. 
6. How long will I have to wait for a 
request for a consultation to be filled? 
The committee tries to fill all requests 
within 48 hours. This is difficult if the 
request comes in on Friday afternoon or 
on New Year's Eve. The Critical Care 
Topics in Bioethics: 
Bioethics and Jehovah's 
Witnesses: 
A brief review 
The treatment of patients who are Jeho-
vah's Wimesses is complicated by ethical 
issues related to transfusion. We will 
briefly review the present state of treat-
ment of]ehovah's Wimesses and discuss 
some of the ethical issues surrounding 
their care. 
It is important to recognize that Jeho-
vah's Wimesses do accept most medical 
2 
Office is closed after 5pm and is also 
closed on weekends and holidays. If you 
need information on the status of your 
request, you can contact the Critical Cart. 
Office or page the chair of the Ethics 
Committee. 
7. Why or when should I write for 
an ethics consult? Should I always 
request one when there is conflict or 
when I am considering withholding or 
withdrawing treatment? There are sev-
eral questions here. Let us start with the 
second one first. It is not always necessary 
to ask fur an ethics consultation when con-
sidering withholding or withdrawing med-
ical treatment. It is perfectly permissible 
to withhold or withdraw medical treat-
ment, assuming there are no ethical ques-
tions, without an ethics consultation. If , 
there is conflict, an ethics consultation 
may be desirable, but again, this depends. 
Often the conflict can be resolved by 
physicians and nurses without the assis-
tance of an ethics consultation team. 
However, if there are ethical questions or 
if there is some kind of ethical tension, thp 
Ethics Committee is ready to help. If yo~ 
have any questions about whether a con-
sultation is necessary, you can contact the 
chair of the Ethics Committee and seek 
her or his advice. 
and surgical treatments. They fullow spe-
cific religious principles in regards to 
blood transfusions which bring them into 
conflict with medical advice. This is based 
on their interpretation of certain biblical 
passages: 
"Only flesh with its soul-its blood- you 
must not eat" 
(Genesis 9:3-4) 
Continued on Page~ 
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"pour its blood out and cover it with 
dust" 
(Leviticus 17:13 -14) 
"Abstain from ... what is strangled and 
from blood" 
does to initiating, withdrawing and with-
holding medical treatments, allows Jeho-
vah's Witnesses to specifically refuse trans-
fusions. They do not forfeit rights to other 
medical therapies aside from this. As with 
(Acts 15:19-21) any other refusal of treatment, they should 
(Dixon, 1981) be made aware of the potential conse-
This refusal dates to a 1945 church quences of such refusal. Documentation of 
decision at a time when transfusions were such a refusal and discussion of the risks 
becoming medically established (Article, should be placed in the medical record to 
1945). Witnesses view these statements as protect the physician and others attending 
forbidding transfusion of whole blood, in the care of the patient. 
packed red blood cells, plasma, white Physicians should attempt to discuss the 
~lood cells, and platelets. Albumin, issue of transfusion prior to surgery or sit-
un~une globulins, and blood factor prepa- uations where transfusions may arise to 
ranons are not specifically proscribed c!ari,fy th~ patie~t's beliefs and the physi..: 
(Mann, 1992). Each Witness must decide ctan s dunes. Thts decision should be 
individually if these latter types of treat- clearly a voluntary one, and occasionally 
ments are acceptable to them. In addition such discussion should be held apart from 
to the above, blood completely removed the presence of others to ensure this. 
from the body cannot be accepted, so that There may be situations where such dis-
autotransfusion of predonated blood is cussions are impossible. In circumstances 
forbidden (Green, 1990). Blood which where the patient's wishes are unknown 
r~mai~s in continuity with the body, (i.e. (i.e. unconscious patient known to be a 
dtalysts or open-heart bypass), arid intra- Jehovah's Witness) the physician may be 
operative salvage where the circulation of forced to err on the side of saving life. If at 
blood extracorporeally is uninterrupted, all possible, consultation with the ethics 
are all generally considered acceptable co~~ittee an~ with legal services may 
(Dixon, 1981). If a Witness accepts trans- asstst m resolvmg ethical dilemmas. 
fusions, they are believed to be cut off Though a particular religious belief may 
from eventual redemption. Some Witness- be held.by others to be 'irrational', present 
es believe that this is the case even if the day ethtcal and legal arguments hold that 
transfusion is accepted for the patient the patient is allowed to follow those 
and/or given to the patient against their belie~ as long as they do not infringe upon 
will. the nghts of others, constitute acts of 
A major precept ofbioethics is that insanity, or contravene present law. The 
patients have a right to autonomy. Auton- principle of autonomy as described in the 
omy is de~ned i~ this setting as the right ~revious paragraphs includes the expres-
to deternune whtch medical treatments are s1on of such a religious tenent. 
~sed, inclll:ding life-saving or life-prolong- In prescribing medical treatment the 
~g therapt~s. Exceptions to this principle risks and benefits must be weighed.'Trans-
mclude panents who demonstrate suicidal fusions, as a medical treattnent, are not 
tendencies, patients who are minors and without risk. In a 1987 review, Walker 
patients who are determined to be i~ca- concluded that there was a 20% risk of 
pable of such decision making. Other ethi- adverse effects, many of which were 
cal co~ntervailing principles may also . minor. Transfusion-associated hepatitis 
come mto play, such as responsibility to and IllV are unusual risks, as are allergic 
other family members. responses. There may be some risk of 
The right to autonomy, extending as it adversely affecting cancer-free survival 
Continued on Page 4 
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after blood transfusions during cancer-
surgery (van Aken, 1989). A recent review 
has emphasized the fact that transfusions 
may be 'overrated', with a significant risk 
of problems (Kitchens, 1993). 
On the other hand, a review of surgery 
in Jehovah's Witness patients suggested 
there may not be an excess morbidity and 
mortality, even in open heart surgery, renal 
transplantation, and total hip replacement 
(Kitchens, 1993). In one study (Nelson, 
1986) 100 patients with standard total hip 
replacement were compared with 100 
Jehovah's Witnesses patients of the the 
same age, sex and health status. Blood loss 
was significantly less and operative time 
shorter with the Jehovah's Witnesses, and 
overall mortality and morbidity were the 
same. The implication of these data is that 
there may be more of a tradeoff in provid-
ing blood transfusion than previously con-
sidered (See also Dixon, 1981). 
Over the years medical techniques have 
been developed to cope with the problem 
of avoiding blood transfusions in this 
group of patients. A variety of alternate 
procedures of varying risk and efficacy are 
available and are the subject of specific 
articles (See Mann et al, 1992). Generally 
accepted strategies include providing crys-
talloids fur fluid replacement, giving 
increased oxygen, minimizing blood loss, 
using microchemical blood analysis to 
reduce phlebotomy loss, using red cell 
scavenging devices, using hypotensive 
anesthesia, giving erythropoetin, and pro-
viding intravenous iron dextran. Experi-
mental approaches with blood substitutes 
are still being refined and currently are not 
of proven value. Special expertise with 
anesthesia and surgery in this group of 
patients may assist in the outcome (Mann, 
1992). 
When the patient without decisionmak-
ing capacity is a Jehovah's Witness, there is 
only one acceptable basis for a religious 
refusal of transfusion by the surrogate. 
That would be in the case that the patient, 
while he or she still had decision making 
capacity, clearly and reliably expressed that 
4 
she/he was a Jehovah's Witness and would 
not accept blood or blood products under 
these circumstances. The physician shou]rl 
seek ethical and legal advice on whether 
the surrogate may decide to forgo treat-
ment on religious grounds. There should 
be evidence to support such a surrogate 
refusal, as in the case of any patient with-
out decision making capacity forgoing 
treatment at a surrogate's request. 
When a patient who is a Jehovah's Wit~ 
ness is pregnant, a refusal of blood or 
blood products may jeopardize the care of 
another who is incapable of decision mak-
ing for themselves. In this situation careful 
consideration by the institutional ethics 
committee and/or legal services is impor-
tant for the reasons described in other sec-
tions. Direct and tangible harm to the 
fetus may occur as a result of forgoing 
transfusion. 
In the case of a minor there is limited 
capacity to make medical decisions due to 
age. The physician should seek ethical and 
legal advice on whether the patient, par-
ents, or another surrogate may decide to 
furgo treatment on religious grounds. 
Most courts have concluded that parents 
cannot refuse blood and blood products 
for a child on religious grounds, since this 
may deprive the child of the opportunity 
to decide as an adult whether to adhere to 
the same religious principles. It may be 
possible that in some special circumstances 
a refusal may be ethically justified (For 
example, a 15 year old patient with termi-
nal cancer refusing further chemotherapy). 
The physician has an obligation to pre-
serve life where possible, and should err 
on the side of such activity in the case of 
minors. 
In reviewing the literature on treatment 
of]ehovah's Witnesses, a number of sug-
gestions emerge. First, that}ehovah's Wit-
nesses be accorded the same right of 
refusal of specific medical therapies that 
other patients are accorded. Second, that a 
discussion of the types of allowed treat-
ment take place, if possible, prior to 





surgery or other procedures. Third, that 
physicians experienced with the treatment 
of these patient be involved in their care, if 
possible. Fourth, that in circumstances of 
an ethical dilemma, consultation with legal . 
services and the institutional ethics com-
mittee be obtained for the couselling and 
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Krank's Korner 
Why I Am Not 
A Health Care Consumer? 
There is a movement today to turn 
health care into a business; it is said that in 
this manner health care will become more 
responsible. It may be that health care 
needs to become more responsible about 
the cost of care. However, in order to do 
this, it is not necessary to use language that 
is misleading. 
Take the new name for patient! We are 
now (remember, at some time, even you, 
fellow health care worker, will join this 
category) health care consumers. There 
are automobile consumers, and· food con-
sumers, and sporting goods consumers. I· 
assume that by making patients health care 
consumers the makers of language are try-
ing to do two things. First, remind health 
care workers that patients have choices 
about where they go for health care and 
second, remind patients that they should 
be more responsible for how they spend 
' their health care dollars. All of those 
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things seem to be reasonable, but that does 
not make patients, especially in a high 
technology hospital like this one, con-
sumers. 
For the essence of consumerism is 
choice. I choose whether I want a car or 
roller blades or Nintendo. I do not choose 
to be admitted as a trauma patient and ifl 
had a choice, I would just as soon pass the 
open heart operation readily available 
here. Most often, if I had a choice, I would 
pass up being a patient for some other sta-
tus, for example, being an Eagles fan. And 
I do not want to be labeled so that anyone 
is treating me as ifl had a choice about 
being a patient. 
The other side of this is that nurses and 
physicians are not misnamed as well. I 
have been reading a lot ofliterature which 
speaks of them as "health care providers." 
What is missing in that description is the 
Continued on Page 6 
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sense that what nurses and physicians 
often "provide" is themselves, that they are 
as much with patients as they are provid-
ing something for patients. 
My worry here is that this misuse oflan-· 
guage will never end. If we do not watch 
out, pretty soon we will have a hierarchy 
based upon a false understanding of medi-
cine and nursing. In addition to health 
care providers, we will have to have 
Upcoming Events: 
May 26th, Auditorium, LVH CC cam-
pus 
"CPR and DNR; have we got the cart 
before the horse?" 
6 
Depamnents of Consumer Services. And 
who knows· who these health care workers 
used to be and what they are supposed to 
be doing? "Why do we not name ourselve~ ' 
as we are, physicians, nurses, technicians, 
therapists of different stripes, etc? At least 
we would know who we are. And perhaps 
our patients would as well. 
KRANK'S KORNER is an irregular fea-
ture of the Ethics Newsktter. 
Look for announcements about an 
upcoming symposium in the fall: "The 
ethics of health care at the beginning and 




P & T HIGHLIGHTS 
The following action were taken at the May 9, 1994 Pharmacy and 
Therapeutics Committee Meeting - James A. Giardina, Director of Pharmacy 
FORMULARY ADDITION REQUESTS 
Rocuronium (Zemuron, Organon) is a 
new nondepolarizing neuromuscular 
blocking agent, which has a quicker onset 
of action with a comparable duration and 
recovery to vecuronium (Norcuron). 
Rocuronium' s potency is similar in young 
and older patients, although both onset and 
recovery are slower in the elderly. To 
date, metabolites have not been detected in 
the plasma or urine, and one third of the 
dose can be recovered in the urine within 
24 hours. In cats, a large portion is 
excreted in bile; no data is available on 
such elimination in humans, but hepatic 
clearance could be significant. In patients 
with renal failure, both total plasma 
clearance and the volume of the central 
compartment did not differ frOm patients 
with normal renal function. However, 
greater volume of dis~bution results in a 
longer elimination half life in this 
population. A bolus dose of 0.6mg/Kg 
has been used to facilitate intubation. 
Doses required to maintain paralysis via 
continuous infusion in critical care patients 
appear to be excessive and hence very 
costly. This fact appears to be due to the 
lack of an active metabolite. Adverse 
rel!ctions to rocuronium have been minimal 
and depending variable, on the study and 
the defmition employed. Patients 
receiving rocuronium have had either no 
increase or a mean increase in heart rate 
(Investigators did not rule <nit concomitant 
drug therapy as a .cause). A transient 
increase in heart rate was also seen in 
children, aged 1 to 5. There were no 
changes in blood pressure reported in the 
several studies reviewed. Histamine 
release has also not been reported in 
premarketing data. Rocuronium has not 
been studied in pregnant women or in 
children less than 3 months old. 
Monitoring similar to the other 
neuromuscular blockers is recommended 
utilizing a peripheral nerve stimulator. In 
summary, rocuronium is an intermediate 
acting neuromuscular blocker with rapid 
onset of action. The committee approved a 
three month trial of this agent in 
Anesthesia controlled areas to coincide 
with a review of this entire class of agents. 
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Aprotinin (Trasylol, Miles) is a bovine 
derived polypeptide that inhibits protease. 
It is indicated for prophylactic use to 
reduce perioperative blood loss and the 
need for blood transfusion in select 
cardiopulmonary bypass surgical patients. 
Aprotinin has antifibrinolytic, hemostatic 
stabilizing and weak anticoagulant effects. 
The specific mechanism of action by which 
it reduces perioperative bleeding is 
unknown, however it appears to be due to 
protection of circulating platelets. 
Aprotinin is rapidly distributed into the 
extravascular space following IV 
administration. It has a plasma half life of 
50 minutes, and a terminal elimination half 
life of 10 hours. Aprotinin is sequestered 
by the kidneys, following glomerular 
filtration. It is stored in the 
phagolysosomes of the proximal tubules 
and has a half life within the kidney of 
almost 24 hours. It is slowly degraded by 
lysosomal enzymes. 
Aprotinin has not been studied in 
pregnancy or pediatrics, therefore the 
manufacturer makes no recommendation 
on use in these patients. Because it is a 
bovine protein, Aprotinin has the potential 
to cause allergic reactions. It should be 
first given as a test dose (lml). Patients 
who have previously received it should 
Table 1: Aprotinin Use Criteria 
PROPHYLAcnC • USED FOR WGH RISK 
OPERATIVE PATIENTS, i.e. 
1. Re-do procedures 
2. Multiple procedures such as valve and CABG 
combination 
3. Procedures involving aneurysm repair or resection 
4. Procedures with artificial surface implantation 
eg. valve conduits, dacron patches, etc. 
5. Previous coagulopathy 
also receive a HI-histamine antagonist 
shortly before the loading dose. In a 
pooled analysis of several studies, a trend 
toward an increased incidence of MI as 
well as increased incidence of saphenous 
vein graft closure was seen. A significant 
increase in renal dysfunction was seen in 
treated vs placebo patients. Most cases 
were not severe and were reversible. In 
some studies, Aprotinin was safely given 
to renal failure patients. Abnormal liver 
function tests have also been reported 
significantly more often in treated patients. 
Aprotinin has been found to prolong the 
ACT and the APTT. However, because 
aprotinin possesses both anticoagulant and 
antifibrinolytic effects, routine heparin 
dosage adjustment is not recommended. 
The manufacturer recommends use of 
standard heparin loading doses and 
redosing based on either a fixed dose 
regimen (weight dosing & duration of 
procedure) or based on heparin levels 
based on a method unaffec~ by aprotinin 
(protamine titration). Aprotinin is given as 
a test dose, then a loading dose followed 
by a pump priming dose and a continuous 
infusion dose. It should be infused 
through its own line. Aprotinin was added 
for a three month therapeutic evaluation in 
cardiothoracic surgery based on the criteria 
in Table 1. 
TIIERAPEt.mC 
1. Unanticipated use due to intraoperative 
impaired hemostasis eg. aspirin use, 
DIC, non-mechanical coagulopathy, etc. 
2. Prolonged cardiopulmonary bypass prolonged 
= > Shrs of cardiopulmonary bypass 
> 3hrs of aortic cross-clamping 
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CONVERTING PATIENTS TO DAILY 
DOSING SCHEDULE 
The committee approved a conversion 
formula for patients who are started on 
once daily drugs at times other than 9AM, 
which is the standard time for giving 'most 
once daily medications at L VH. The 
formula calls for the second and 
subsequent doses to be given at 9AM if the 
frrst dose was given prior to midnight. If 
the first dose is given after midnight, the 
next dose (9AM) is skipped and the 
regular schedule started on the following 
day. Exceptions to this formula include 
amphotericin B, aminoglycosides and 
vancomycin, medications ordered at 
specific times, and daily meds given at 
6PM (digoxin, lovastatin & simvastatin). 
TO MONITOR OR NOT TO MONITOR 
(VANCO, THAT IS) 
The committee reviewed and approved guidelines on the appropriate use of serum 
vancomycin monitoring. The guidelines result from a literature review which shows that 
vancomycin is only minimally nephrotoxic or ototoxic unless combined with an 
aminoglycoside (gentamicin, tobramycin, etc.) This conclusion comes after 36 years of 
clinical use of vancomycin. With this in mind, the recommendation is that vancomycin 
trough levels may be useful (but are not mandatory) in the following situations: 
1. Patients receiving combination therapy with other nephrotoxic agents ie. vancomycin + an aminoglycoside 
(gentamicin, tobramycin, or amikacin). 
2. Patients on hemodialysis to aid in determining time for next dose (usual adult dose in lGm weekly). 
3. Patients being given higher-than-usual doses of vancomycin for resistant or CNS infection. 
4. Patients with rapidly changing renal function. 
vancomycin serum levels should not be routinely done in patients with normal renal 
function and with susceptible organisms. There appears to be no clinical benefit to fme-
tuning dosages to keep the level of vancomycin exactly within the peak/trough reference 
range. The usual adult dose for patients with normal renal function is 15 mg/Kg IV Q12H 
or 1 Gm IV Q12H. The pediatric dose is 0.6Gmlm2 IV Q12H. 
DRUG USE E.VALUATION (DUE) CORNER 
ALTEPLASE 
Due to questions regarding therapy complications, the committee began a monthly review of 
alteplase (t-PA) use. In April, 5 patients received standard regimen and 2 patients received 
accelerated dosing. One patient in the standard therapy group had multiple hematomas which 
resolved without intervention. 
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GI/COLORECTAL SURGICAL PROPHYLAXIS 
This study was performed as a follow up to a similar study performed in April 1993. Cases 
were identified from the surgical schedule and included all patients not on antibiotics 
preoperatively, without documented signs of infection and/or complications post op. Table 2 
shows the results of the findings. 
In summary, the fmdings are that the antibiotic was given closer to incision time, and more 
appropriate agents were selected, but duration of therapy increased rather than being 
reduced to the recommended single dose. 
Table 2: Sun~ical ProPhylaxis GI/Colorectal Surgery 
SUMMARY OF APRIL 1993 APRIL RECOMMENDED 
RESULTS 1994 STANDARD 
#PATIENTS 57 71 
#ANALYZED, 
EXCLUDING 51 65 
TREATMENT 
CASES 
TIME OF DOSE 
RELATED TO 1-2.5 H 0.5- lH o ..5- 2 H 
INCISION TIME 
AGENTS USED AMPICILLIN/SO 12 3 GI:CEFAZOLIN 
AMP/SB + MNTZ 3 0 
CEFEZOLIN 18 37 COLO: 
CEFAZOLIN + MNTZ 13 24 CEFAZOUN + MTNZ OR 
CEFOTETAN 2 1 CEFOTETAN 
NO ANTIBIOTICS 8 9 
CIPRO 1 0 ALTERN: V ANCO (PEN 
MTNTZ 5 0 ALLERGIC) 
+1- GENT 
AVERAGE LENGTH 
OF SURGICAL 20.3H 31H SINGLE DOSE 
PROPHYLAXIS 
Patients were identified from the daily OR schedule at CC. Charts were reviewed for 
surgical procedure performed, antibiotic used for surgical prophylaxis including dose, time 
given and duration of therapy. Operative notes, progress notes, and post-op vital signs were 




The committee reviewed 4 months usage of this agent, which was given conditional approval 
in December 1993. The results together with the usage criteria are ih Table 3. 
Table 3: Summary of the Results 
#PATIENTS RECEIVING IV DILT 26 
#PATIENTS RECEMNG IV 40 
VERAPAMIL 
SCOPE: 
# PATIENTS LOCATED IN CRIT 26/26 (100%) 
CARE .. 
AVERAGE LENGTH OF 47.3H (RANGE 0.5-142.5H) 
THERAPY 
CRITERIA FOR USE: 
INADEQUATE HR CONTROL 
POST VERAPAMIL 20MG & lH 2 
INFUSION 
~ 
INTOLERANCE TO A 5MG 
DOSE VERAPAMIL W/ 4 
DECREASE BP 
BASEUNE SYMPTOMATIC 
HYPOTENSION < 90MMHG 
REQUIRING PRESSOR AGENTS 
OR, EF ~ 35%, &/OR PCWP 19 
2_20MMHG 
TOTAL: 25/26(96%) 
ADVERSE CUNICAL EVENTS: 
SYMPTOMATIC HYPOTENSION 
< 90MMHG REQUIRING D/C OF . 4(15.4%) 
IV DIL TIAZEM 
96% of the IV diltiazem use was according to the established criteria. The length of 
continuous infusion varied from 0.5H to 142.5H. The length of therapy appears to vary per 
patient with the optimal infusion length to be determined. The committee approved the 
addition of IV diltiazem to the formulary contingent upon the results of a second fo~ month 





Cedar Crest & 1-78 
P.O. Box 689 
Allentown, PA 18105-1556 
Medical Staff 
Progress Notes 
Joseph A. Candio, M.D. 
President, Medical Staff 
John E. Castaldo, M.D. 
President-elect, Medical Staff 
John Jaffe, M.D. 
Past President, Medical Staff 
John W. Hart 
Vice President 
Rita M. Mest 
Medical Staff Coordinator 
Janet M. Laudenslager 
Physician Relations 
Managing Editor 
Medi.ctd ExecuJ#.ve Commlltu 
J011eph A. Candio, M.D. 
John E. Caltaldo, M.D. 
llobett V. CuiiiiDinp, M.D. 
Carl F. D'Anlelo, M.D. 
R.obert B. Doll, M.D. 
John D. Farrell, M.D. 
Jobn P. FIIZJibbona, M.D. 
J010ph W. Gutinpr, M.D. 
Mark A. Gitdoman, M.D. 
Jamea J. Gooclnau, M.D. 
Thomaa A. Hutchinlon, M.D. 
John Jaffe, M.D. 
Michael W. Kaufmann, M.D. 
Mark C. Lelltor, M.D. 
llona1d A. Lutz, M.D. 
Alpbonae A. Maft"oo, M.D. 
R.obert X. Murphy, Jr., M.D. 
Paul E. Nurict 
Walter J. Olamaki, M.D. 
Mark A. Olborne, M.D. 
R.andy A. Jloaen, M.D. 
NormanS. Sarachot, M.D. 
John J. Shane, M.D. 
John D. VanBrakle, M.D. 
H~y S. White, M.D. 
Geary L. Yeilley, M.D. 





Permh No. 1922 
Jle&tll Sllll/.,.,... Nllla 
is published monthly to 
iaform tbe Lehigh Valley 
Hospital Medical Staff and 
employees of important issues 
conc:emina the Medical Staff. 
Articles should be submitted 
to Jauet M. l.audenslaaer, 
Physician Relations, U43 S. 
Cedar Crest .BouleYard, 
Allentown, PA 18103, by the 
rarst of each month. If you 
bave any questions about the 
newsletter, please call Ms. 
Laudenslager at 402-9853. 
Lehigh Vtdlq HospiJIIl is an 
eqlllll opportunlly employer. 
M/FIHIV 
